Another retraction for Pfizer’s experimental cancer treatment figitumumab » 6794 BJC_newblue_V1.qxd
Retraction Watch
Tracking retractions as a window into the scientific process
Pages
- About Adam Marcus
- About Ivan Oransky
- The Retraction Watch FAQ, including comments policy
- The Retraction Watch Store
- The Retraction Watch Transparency Index
- Upcoming Retraction Watch appearances
- What people are saying about Retraction Watch
Recent Comments
 | Bob O'H on Not your data: Nursing paper r… |
 | amarcus41 on “Ephemeral nature”… |
 | Rob Siebers on Don’t feel so bad, The A… |
Retraction posts by author, country, journal, subject, and type
Follow Ivan on Twitter
- “Ephemeral nature” of samples — and co-author — leads to ninth Jesús Lemus retraction bit.ly/10jpoSG 40 minutes ago
- RT @AHCJ_Pia: After 5-year FOIA fight, documents show ties between researchers, officials in Lyme wars bit.ly/14tUDuu 1 hour ago
- From @garyschwitzer, warnings about drug company-funded mental health websites ht.ly/lfiKf 3 hours ago
Follow Adam on Twitter
- Locusts may hold key to a better understanding of the blood-brain barrier: ncbi.nlm.nih.gov/pubmed/23671124 6 days ago
- Dahlberg: only 10% of allegations last year came from NIH work. 1 week ago
- ORI's John Dahlberg: misconduct allegations up sharply in recent years. 422 in 2012; 131 in Q1 2013. 1 week ago
